Akebia Therapeutics, Inc 10-K for FY2025
Akebia Therapeutics, Inc. (AKBA)
10-K
2026-02-26
For: 2025-12-31
View Original
Added on
April 11, 2026
About this 10-K
Akebia Therapeutics, Inc filed this 10-K on February 26, 2026, covering the fiscal year ended December 31, 2025 (FY2025).
Headline figures
Fiscal year ended December 31, 2025, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $236.2M
- up 47.5% from $160.18M a year earlier
- Net loss
- $5.35M
- compared with a net loss of $69.41M a year earlier
- Diluted EPS
- -$0.02
- compared with -$0.33 a year earlier